Atherosclerosis and Lipoproteins |
From Experimental Cardiovascular Research (P.D., G.N.F., S.J., J.N.), Department of Medicine, Lund University, University Hospital MAS, Malmö, Sweden; the Atherosclerosis Research Center (P.D., B.C., S.O., J.Y., P.K.S.), Burns and Allen Research Institute, Division of Cardiology, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, Calif; and the Department of Biomedical Laboratory Science, Health, and Society (G.N.F.), Malmö University, Malmö, Sweden.
Correspondence to Paul Dimayuga, PhD, Davis Research Building, Room 1064, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048. E-mail DimayugaP{at}cshs.org
| Abstract |
|---|
|
|
|---|
Key Words: neointima B cells arterial injury Rag-1 knockout mice
| Introduction |
|---|
|
|
|---|
has also been shown to contribute to plaque formation.10
See page 523
Immune-mediated modulation of the response to arterial injury has also been postulated to play a role in neointimal formation.11,12 Studies on immune modulation of the response to injury have focused primarily on T-lymphocyte effector functions. The main finding of those studies indicates that interferon-
, as opposed to its proatherogenic role in cholesterol-induced plaque formation, 10,13 plays an inhibitory role in the response to arterial injury.11,14 It is unclear what role B cells may have in arterial injury. Some studies have implicated the humoral immune system, particularly the antibodies,15 as playing a role in injury and have suggested that there may be antibody-mediated responses to arterial injury.
To test the hypothesis that B cells may modulate neointimal thickening after arterial injury, we used the carotid cuff injury model in immune-deficient Rag-1 knockout (KO) mice,16 which lack mature B and T cells, and the transfer of B cells from spleens of wild-type (WT) mice into Rag-1 KO mice. Rag KO mice have previously been used to assess B-lymphocyte survival and renewal kinetics after adoptive transfer.17 The mice were fed either normal chow or a western-type diet to examine the effect of diet on B-cell function after injury. The effects on neointimal formation were then assessed.
Our results show a significant increase in neointimal formation in immune-deficient Rag-1 KO mice compared with WT mice. In addition, we show that reconstitution with B cells reduced neointimal formation in Rag-1 KO mice fed normal and western diets. The possible role of IgM in this response and implications of the findings are also discussed.
| Methods |
|---|
|
|
|---|
Splenocyte Reconstitution
Spleen cells from age-matched WT mice fed the same diet were isolated as previously described.20 Briefly, individual spleens were sliced into 2-mm pieces and pressed through a sterile wire mesh (Cellector, Bellco Glass). Red blood cells were lysed, and the cells were suspended in PBS/1% FBS (GIBCO-BRL). Cells were then negatively selected by using paramagnetic beads coated with anti-mouse Thy1.2 antibody to deplete T cells and a magnetic particle concentrator, according to the manufacturers recommendations (Dynal A.S. Norway). Pilot experiments demonstrated
90% purity for B cells with the use of FITC-conjugated anti-mouse CD19 monoclonal antibody (Pharmingen/Becton Dickinson) by fluorescence-activated cell sorter analysis (FACSort, Becton Dickinson). Negatively selected splenocytes in PBS were then injected via the tail vein of Rag-1deficient mice (2 to 4x107 cells per mouse) 48 hours before injury. Tissue was collected as described above.
Morphometric Analysis and Immunostaining
Frozen sections 6 to 8 µm thick were collected from the injured carotid arteries as described previously.18,19 Briefly, 4 or 5 sections were collected per slide for approximately half of the injured segment. Four slides equally spaced from first to last were then stained with hematoxylin and eosin, and the vessel area was measured by using computer-assisted morphometric analysis (Olympus Micro Image).
For immunostaining, the following antibodies were used: rat anti-mouse MOMA-2 (BMA Biomedicals), FITC-labeled anti
-actin (Sigma Chemical Co), biotinylated anti-mouse IgM (Vector Laboratories), and biotinylated anti-mouse IgG (Sigma). Biotinylated rabbit anti-rat IgG (Vector) was used for MOMA-2 detection. Nonimmune serum, omission of primary antibody, and isotype IgG/FITC (for
-actin) were used as a negative control. Contralateral arteries served as an uninjured control. A DAB detection kit (Vector) was used for color development.
Serum Cholesterol
Serum cholesterol was determined as previously described.18 Briefly, serum was collected 21 days after injury during euthanasia. Cholesterol levels were determined by using a commercially available kit (Sigma).
Enzyme-Linked Immunosorbent Assay
Relative serum immunoglobulin levels were determined by using an isotyping ELISA kit from Southern Biotechnology Associates. Briefly, 96-well ELISA plates were coated with the capture antibody overnight, blocked with 1% BSA, and incubated overnight with sera diluted 1:100 in PBS. Wells were washed and incubated with horseradish peroxidaseconjugated IgM and IgG2a detection antibody for 1 hour. The substrate for color development was ABTS, as provided in the kit. Optical density was recorded 20 minutes later on a SpectraMax 190 plate reader (Molecular Devices).
Statistical Analysis
Data are presented as mean±SD. Statistical comparisons were made by the Mann-Whitney test because of the small sample size.21 Significance was set at a value of P<0.05.
| Results |
|---|
|
|
|---|
|
Injury to the carotid artery of immune-deficient Rag-1 KO mice fed a western diet compared with WT mice also on western diet resulted in significantly increased neointimal formation, medial area, and intima-to-media ratio (P<0.05, Table and Figure 1A and 1B). The neointima of both groups consisted predominantly of smooth muscle cells (SMCs), as determined by SMC
-actin staining (Figure 1D and 1E). Serum cholesterol levels were not significantly different between the 2 groups (Table). Monocyte/macrophages as detected by MOMA-2 stain were minimal in WT and Rag-1 arteries 21 days after injury (Figure 1F and 1G).
|
Compared with WT mice fed normal chow, WT mice fed a western diet had significantly increased cholesterol levels but similar neointimal formation (Table). Similarly, compared to Rag-1 KO mice fed normal chow, Rag-1 KO mice fed a western diet had increased cholesterol levels but only a slight augmentation of neointimal formation (P=0.23, Table) and no difference in the intima-to-media ratio.
B-Cell Reconstitution of Rag-1 KO Mice
The transfer of B cells from WT mice fed normal chow to Rag-1 KO mice resulted in significantly reduced neointimal formation compared with that in Rag-1 KO mice without B-cell transfer (Figure 2A; P<0.05). Reconstitution of western dietfed Rag-1 KO mice with B cells enriched from WT mice fed a western diet also resulted in significantly reduced neointimal formation after injury (P<0.05, Figure 1C and Figure 2B). The neointima consisted mostly of SMCs (Figure 1F), with minimal staining for monocytes/macrophages (Figure 1I). The medial area was similar between the 2 groups (Table), but the intima-to-media ratio was decreased in the B-cellreconstituted mice compared with unreconstituted mice (Table, P<0.05).
|
Increased IgM Presence in Injured Arteries
An increased presence of IgM was observed in the right carotid arteries of WT mice 21 days after injury (Figure 3A). This was observed in the media and the neointima. IgM was not observed in the media of the uninjured contralateral artery (Figure 3B) or in the injured arteries of Rag-1 KO mice (Figure 3C). The presence of IgM was also observed in the injured arteries of reconstituted Rag-1 KO mice (Figure 3D), indicating that the B cells transferred were viable.
|
Presence of IgG in Neointima
The presence of IgG was also detected in the injured carotid arteries of the WT mice 21 days after injury, but unlike IgM, IgG was localized mainly in the neointima and adventitia, with faint patchy stains in the media (Figure 3E). Uninjured contralateral arteries had only faint adventitial stains (Figure 3F), whereas no IgG was detected in the injured arteries of the Rag-1 KO mice (Figure 3G). The arteries of B-cellreconstituted mice had a staining pattern similar to that of injured WT arteries, with IgG mainly in the neointimal layer (Figure 3H).
Serum Immunoglobulin
In contrast to WT mice, Rag-1 KO mice had no detectable serum IgM or IgG2a before injury (Figure 4). Reconstitution of Rag-1 KO mice with B cells slightly increased serum IgM on the day of injury (D0 in Figure 4), but IgG levels remained undetectable. IgM and IgG levels were at or near WT levels 21 days after injury in the Rag-1 KO mice with B-cell reconstitution (Figure 4), whereas Rag-1 KO mice without B-cell transfer had no detectable immunoglobulins. Similar results were observed in the normal chowfed mice (not shown).
|
| Discussion |
|---|
|
|
|---|
The use of a western diet did not alter the outcome in the WT mice, but there was a slight augmentation of neointimal formation in Rag-1 KO mice. This finding suggests that the diet may play a role in the response of the arterial wall to injury when the immune system is compromised. The difference in the medial area coupled with an increase in the EEL area in injured Rag-1 KO arteries suggests increased tissue remodeling. This was observed only after injury, because the age-matched uninjured arteries of WT and Rag-1 KO groups had similar areas. It is interesting that immune deficiency, but not the western diet, seems to have had an effect on this process in the present study. A similar increase in medial area was observed in injured arteries of apoE KO mice fed a western diet, suggesting that cholesterol levels must be profoundly increased to have any effect on injury-induced neointimal formation.18 Our results show that the B-cell response in experimental injury was not significantly affected by the diet.
The presence of IgM in the injured arteries of WT mice suggests that cuff injury increases tissue permeability or the localization of antibodies to neoantigens expressed in the arterial wall after injury. Tissue permeability has been described to be a possible source of medial SMC activation in the rabbit cuff injury model.24 However, the present results also suggest that tissue permeability may lead to increased IgM in the injured tissue and may modulate the response to injury. It is also possible that the cuff placement disrupts lymphatic drainage from the affected area. However, the localization of IgG mainly in the neointima would not support this notion. The presence of IgG mainly in the neointimal layer is in agreement with a previous study by Hansson et al25 in a rabbit injury model. It is not clear whether the localization of IgG in the neointima has any functional significance. IgM and IgG in the vascular wall have been previously described in plaques of LDL receptordeficient mice,26 suggesting a role for localized antibodies in atherogenesis. In our previous study, immunization with oxidized LDL reduced injury-induced neointimal thickening in hypercholesterolemic rabbits.15 Although arterial tissue was not examined for the presence of antibodies in that study, antibody titers against oxidized LDL of the IgG isotype were similar between immunized and nonimmunized rabbits. This observation is not in agreement with other immunization studies on the antibody response,13 although immunization is seemingly beneficial in both situations. The Rag-1 KO mice used in the present study have no mature B cells and T cells; therefore, reconstitution with B cells alone would suggest lack of T helper cellmediated antibody maturation from the IgM class after injury. However, the presence of IgG in the reconstituted mice 21 days after injury suggests the presence of memory B cells. Which of the 2 isotypes is important in the response to injury is not clear. The beneficial effects of intravenous immunoglobulin that have been reported in atherosclerosis6 and injury27 in mice were found to be primarily through the modulation of T helper cell function. In the present study, the presence of antibodies in the B-cellreconstituted Rag-1 KO mice, which lack mature T cells, suggests a mechanism not involving the modulation of T helper cell functions.
Although the mechanism is currently unclear, one way for IgM to play a role in arterial injury could be by the enhancement of phagocytosis by macrophages. However, the low presence of macrophages in the injured arteries in the present study would argue against this. IgM may also be involved in complement activation, as has been reported in early atherosclerotic lesions (Torzewski et al28). The tissue presence of IgM, but not IgG, has been demonstrated in ischemia/reperfusion injury, which has also been shown to be mediated by IgM and complement. The role of IgM and complement in mediating injury in that report was further supported by an apparent lack of injury in Rag KO mice.29,30 Although the present study and the others cited identify a role for IgM in tissue injury, we propose that IgM may have an inhibitory effect on neointimal formation in arterial injury.
IgM has been proposed to be a first line of defense for the organism, as supported by a study in which B-cell reconstitution of Rag-2 KO mice resulted in a rapid normalization of serum IgM levels despite low numbers of B cells.17 In the present study, serum levels of IgM, but not IgG, were detectable at very low amounts in the reconstituted Rag-1 KO mice 48 hours after adoptive cell transfer. Our results suggest that natural antibodies may have effector functions not clearly defined that may yet explain our findings.
In summary, the present study identified a possible role for the humoral immune response in arterial injury and suggests that B cells may be important in this response. This was confirmed in normal diet and western diet-fed mice. Antibodies of the IgM and IgG isotypes were detected in different areas of the injured artery, suggesting isotype specificity in the modulation of neointimal formation after injury.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received December 27, 2001; accepted January 16, 2002.
| References |
|---|
|
|
|---|
2.
Ameli S, Hultgårdh-Nilsson A, Regnstrom J, Calara F, Yano J, Cercek B, Shah PK, Nilsson J. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol. 1996; 16: 10741079.
3.
Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hansson GK. LDL immunization induces T-celldependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol. 2001; 21: 108114.
4.
George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, Shaish A, Kopolovic J, Wick G, Harats D. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol. 1999; 19: 505510.
5. Afek A, George J, Shoenfeld Y, Gilburd B, Levy Y, Shaish A, Keren P, Janackovic Z, Goldberg I, Kopolovic J, et al. Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice. Pathobiology. 1999; 67: 1925.[CrossRef][Medline] [Order article via Infotrieve]
6. Nicoletti A, Kaveri S, Caligiuri G, Bariety J, Hansson GK. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest. 1998; 102: 910918.[Medline] [Order article via Infotrieve]
7. Zhou X, Hansson GK. Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand J Immunol. 1999; 50: 2530.[CrossRef][Medline] [Order article via Infotrieve]
8.
Zhou X, Nicoletti A, Elhage R, Hansson GK. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation. 2000; 102: 29192922.
9.
Laurat E, Poirier B, Tupin E, Caligiuri G, Hansson GK, Bariety J, Nicoletti A. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation. 2001; 104: 197202.
10. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. IFN-gamma potentiates atherosclerosis in apoE knock-out mice. J Clin Invest. 1997; 99: 27522761.[Medline] [Order article via Infotrieve]
11.
Hansson GK, Holm J, Holm S, Fotev Z, Hedrich H-J, Fingerle J. T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci U S A. 1991; 88: 1053010534.
12.
Remskar M, Li H, Chyu KY, Shah PK, Cercek B. Absence of CD40 signaling is associated with an increase in intimal thickening after arterial injury. Circ Res. 2001; 88: 390394.
13.
Whitman SC, Ravisankar P, Elam H, Daugherty A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol. 2000; 157: 18191824.
14.
Hansson GK, Holm J. Interferon-
inhibits arterial stenosis after injury. Circulation. 1991; 84: 12661272.
15. Nilsson J, Calara F, Regnstrom J, Hultgårdh-Nilsson A, Ameli S, Cercek B, Shah PK. Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits. J Am Coll Cardiol. 1997; 30: 18861891.[Abstract]
16. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1 deficient mice have no mature B and T lymphocytes. Cell. 1992; 68: 869877.[CrossRef][Medline] [Order article via Infotrieve]
17.
Agenes F, Freitas AA. Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J Exp Med. 1999; 189: 319329.
18.
Oguchi S, Dimayuga P, Zhu J, Chyu K-Y, Yano J, Shah PK, Nilsson J, Cercek B. Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscler Thromb Vasc Biol. 2000; 20: 17291736.
19.
Chyu K-Y, Dimayuga P, Zhu J, Nilsson J, Kaul S, Shah PK, Cercek B. Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res. 1999; 85: 11921198.
20. Barth RJ, Bock SN, Mule JJ, Rosenberg SA. Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes. J Immunol. 1990; 144: 15311537.[Abstract]
21. Murphy E. Biostatistics in Medicine. Baltimore, Md: Johns Hopkins University Press; 1982.
22. Marusic A, Grcevic D, Katavic V, Kovacic N, Lukic IK, Kalajzic I, Lorenzo JA. Role of B lymphocytes in new bone formation. Lab Invest. 2000; 80: 17611774.[Medline] [Order article via Infotrieve]
23. Boyce DE, Jones WD, Ruge F, Harding KG, Moore K. The role of lymphocytes in human dermal wound healing. Br J Dermatol. 2000; 143: 5965.[CrossRef][Medline] [Order article via Infotrieve]
24.
De Meyer GRY, Van Put DJM, Kockx MM, Schil PV, Bosmans R, Bult H, Buyssens N, Vanmaele R, Herman AG. Possible mechanisms of collar-induced intimal thickening. Arterioscler Thromb Vasc Biol. 1997; 17: 19241930.
25. Hansson GK, Bondjers G, Nilsson LA. Plasma protein accumulation in injured endothelial cells: immunofluorescent localization of IgG and fibrinogen in the rabbit aortic endothelium. Exp Mol Pathol. 1979; 30: 1226.[CrossRef][Medline] [Order article via Infotrieve]
26.
Palinski W, Tangirala RK, Miller E, Young SG, Witztum JL. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol. 1995; 15: 15691576.
27. Keren G, Keren P, Barshack I, Pri-Chen S, George J. The effect of intravenous immunoglobulins on intimal thickening in a mouse model of arterial injury. Atherosclerosis. 2001; 159: 7783.[CrossRef][Medline] [Order article via Infotrieve]
28.
Torzewski M, Torzewsky J, Bowyer DE, Waltenberger J, Fitzsimmons C, Hombach V, Gabbert HE. Immunohistochemical localization of the terminal complex of human complement and smooth muscle cell
-actin in early atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1997; 17: 24482452.
29.
Weiser MR, Williams JP, Moore FD Jr, Kobzik L, Ma M, Hechtman HB, Carroll MC. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med. 1996; 183: 23432348.
30.
Williams JP, Pechet TTV, Weiser MR, Reid R, Kobzik L, Moore FD Jr, Carroll MC, Hechtman HB. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol. 1999; 86: 938942.
This article has been cited by other articles:
![]() |
P. C. Dimayuga, F. H. Y. Cesena, K.-Y. Chyu, J. Yano, A. Amorn, M. C. Fishbein, P. K. Shah, and B. Cercek Natural antibodies and complement modulate intimal thickening after arterial injury Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2009; 297(5): R1593 - R1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strom, M. Wigren, A. Hultgardh-Nilsson, A. Saxena, M. F. Gomez, S. Cardell, G. N. Fredrikson, and J. Nilsson Involvement of the CD1d Natural Killer T Cell Pathway in Neointima Formation After Vascular Injury Circ. Res., October 12, 2007; 101(8): e83 - e89. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Dimayuga, H. Li, K.-Y. Chyu, G. N. Fredrikson, J. Nilsson, M. C. Fishbein, P. K. Shah, and B. Cercek T Cell Modulation of Intimal Thickening After Vascular Injury: The Bimodal Role of IFN-{gamma} in Immune Deficiency Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2528 - 2534. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shoenfeld, R. Wu, L. D. Dearing, and E. Matsuura Are Anti-Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective? Circulation, October 26, 2004; 110(17): 2552 - 2558. [Full Text] [PDF] |
||||
![]() |
E. P. Gurfinkel, R. Leon de la Fuente, O. Mendiz, and B. Mautner Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study: One-year follow-up Eur. Heart J., January 1, 2004; 25(1): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Fredrikson, I. Soderberg, M. Lindholm, P. Dimayuga, K.-Y. Chyu, P. K. Shah, and J. Nilsson Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 879 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Hansson The B Cell: A Good Guy in Vascular Disease? Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 523 - 524. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |